Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Pediatric Preclinical Testing Consortium Evaluation of the Novel Anti-Microtubule Drug E7130 in Xenograft Models of Early T-Cell Precursor Acute Lymphoblastic Leukemia

Richard B. Lock, PhD, Kathryn Evans, Connor D Jones, Narimanne El-Zein, Katerina Bendak, PhD, Cara E Toscan, PhD, Chelsea Mayoh, Stephen W Erickson, PhD, Beverly A Teicher, PhD, Malcolm A Smith, MD PhD

Blood (2019) 134 (Supplement_1): 3875.

https://doi.org/10.1182/blood-2019-123867

Published: 2019

Journal Articles

An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD

Blood (2017) 130 (19): 2131–2145.

https://doi.org/10.1182/blood-2017-05-782466

Published: 2017

Includes: Supplemental data

Journal Articles

Proliferating CLL Cells Express Abundant But Transcriptionally Compromised TP53 Protein

Jesvin J Samuel, BTech, MRes, Alice H Wignall, BSc, Hishyar Najeeb, BVMS, MSc, Aneela Majid, PhD, Sandrine Jayne, PhD, George D Jones, BSc, MSc, D.Phil., Salvador Macip, MD, PhD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath

Blood (2013) 122 (21): 4134.

https://doi.org/10.1182/blood.V122.21.4134.4134

Published: 2013

Journal Articles

Whole Genome Sequence Analysis of Primary Myelofibrosis.

Jason D. Merker, Krishna Roskin, Dana Ng, Cuiping Pan, Dianna G. Fisk, Carol D. Jones, Linda Gojenola, Michael J. Clark, Bing Zhang, Michael Cherry, Michael Snyder, Scott D. Boyd, James L. Zehnder, Andrew Z. Fire, Jason Gotlib

Blood (2012) 120 (21): 2863.

https://doi.org/10.1182/blood.V120.21.2863.2863

Published: 2012

Journal Articles

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

Sally Arai, Bita Sahaf, Balasubramanian Narasimhan, George L. Chen, Carol D. Jones, Robert Lowsky, Judith A. Shizuru, Laura J. Johnston, Ginna G. Laport, Wen-Kai Weng, Jonathan E. Benjamin, Joanna Schaenman, Janice Brown, Jessica Ramirez, James L. Zehnder, Robert S. Negrin, David B. Miklos

Blood (2012) 119 (25): 6145–6154.

https://doi.org/10.1182/blood-2011-12-395970

Published: 2012

Includes: Supplemental data

Journal Articles

High-Throughput Immunoglobulin Gene Sequencing Quantifies Minimal Residual Disease in CLL with 10e-6 Sensitivity and Strongly Predicts Relapse After Allogeneic Hematopoietic Cell Transplantation

Aaron C. Logan, MD, PhD, Malek Faham, MD, PhD, Victoria Carlton, PhD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Tom Willis, PhD, Carol D. Jones, Melody B. Zhang, PhD, Amna N. Waqar, James L. Zehnder, MD, David B. Miklos, MD, PhD

Blood (2011) 118 (21): 2542.

https://doi.org/10.1182/blood.V118.21.2542.2542

Published: 2011

Journal Articles

High-Throughput VDJ Sequencing Is Superior to Quantitative PCR and Flow Cytometry for the Quantification of Minimal Residual Disease In Chronic Lymphocytic Leukemia After Hematopoietic Cell Transplantation.

Aaron C. Logan, MD, PhD, Chunlin Wang, PhD, Bita Sahaf, PhD, Carol D. Jones, B.A., Eleanor L. Marshall, Ismael Buno, PhD, Andrew Z. Fire, PhD, Michael Mindrinos, PhD, James L. Zehnder, M.D., Scott D. Boyd, MD, PhD, David B. Miklos, MD, PhD

Blood (2010) 116 (21): 1290.

https://doi.org/10.1182/blood.V116.21.1290.1290

Published: 2010

Journal Articles

Identification of Novel LNK Mutations In Patients with Chronic Myeloproliferative Neoplasms and Related Disorders

Stephen T. Oh, M.D., Ph.D., Jacob M. Zahn, Ph.D., Carol D. Jones, B.A., Bing Zhang, M.D., M.S., Mignon L. Loh, M.D., Hagop Kantarjian, MD, Erin F. Simonds, B.S., Robert V. Bruggner, B.S., Parveen Abidi, Ph.D., Georges Natsoulis, Ph.D., John Bell, M.S., Jason Buenrostro, B.S., Garry P. Nolan, Ph.D., James L. Zehnder, M.D., Hanlee P. Ji, M.D., Jason Gotlib, M.D., M.S.

Blood (2010) 116 (21): 315.

https://doi.org/10.1182/blood.V116.21.315.315

Published: 2010

Journal Articles

Identification of a Novel Splice Donor Mutation In the Thrombopoietin Gene In a Philippine Family with Hereditary Thrombocythemia

Jason Gotlib, Bing Zhang, Carol D. Jones, Jonathan Riess, Wendy B. Wong, Erin F. Simonds, Matthew B. Hale, Parveen Abidi, Janell McClung, Garry P. Nolan, Stephen T. Oh, James L. Zehnder

Blood (2010) 116 (21): 3086.

https://doi.org/10.1182/blood.V116.21.3086.3086

Published: 2010

Journal Articles

Transforming Transfusion Practices: High Dose Aminocaproic Acid and Vitamin K for the Management of Thrombocytopenia

Suzanne Rossi, BA, Patricia A. Locantore-Ford, MD, Lawrence D Jones, RPh

Blood (2008) 112 (11): 4547.

https://doi.org/10.1182/blood.V112.11.4547.4547

Published: 2008

Journal Articles

Mature Results of a Prospective Trial of Rituximab in Patients (Pt) with Post Transplant Lymphoproliferative Disorder (PTLD) Unresponsive or Ineligible for Reduced Immunosuppression (RIS).

Jeff P. Sharman, MD, Donald E. Tsai, M.D., Clare J. Twist, M.D., Steven M. Horwitz, M.D., Carol D. Jones, M.D., Sandra J. Horning, M.D.

Blood (2006) 108 (11): 2755.

https://doi.org/10.1182/blood.V108.11.2755.2755

Published: 2006

Journal Articles

Low Molecular Weight Heparin Modulates the Binding and Reactivity of Factor Xa towards Basic Pancreatic Trypsin Inhibitor: A Surface Plasmon Resonance and Kinetics Study.

Pierre F. Neuenschwander, PhD, Kimberly J. Baker-Deadmond, PhD, Angela D. Jones, BS

Blood (2006) 108 (11): 1623.

https://doi.org/10.1182/blood.V108.11.1623.1623

Published: 2006

Journal Articles

Dasatinib (SPRYCEL®) in Patients (pts) with Previously Untreated Chronic Myelogenous Leukemia (CML) in Chronic Phase (CML-CP).

Jorge Cortes, S. O’Brien, D. Jones, G. Borthakur, F. Giles, C. Nicaise, H.M. Kantarjian

Blood (2006) 108 (11): 2161.

https://doi.org/10.1182/blood.V108.11.2161.2161

Published: 2006

Journal Articles

AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has Significant Activity in Imatinib-Resistant Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome Positive Acute Lymphoid Leukemia (Ph + ALL).

Hagop M. Kantarjian, MD, O. Ottman, MD, Jorge Cortes, MD, M. Wassman, MD, L. Wunderle, MD, K. Bhalla, MD, D. Jones, MD, A. Hochhaus, MD, P. Rae, L. Alland, MD, M. Dugan, MD, M. Albitar, MD, Francis Giles, MD

Blood (2005) 106 (11): 37.

https://doi.org/10.1182/blood.V106.11.37.37

Published: 2005

Journal Articles

First Molecular Characterization of a Family with Combined FV and FVII Deficiency.

Ilana Traynis, Carol D. Jones, Connie B. Gibb, Suchitra Acharya, MD, James L. Zehnder, MD

Blood (2005) 106 (11): 1786.

https://doi.org/10.1182/blood.V106.11.1786.1786

Published: 2005

Journal Articles

Identification of a Novel Factor V A2 Domain Tyrosine Deletion Mutation in a Patient with Factor V Deficiency and Bleeding.

Carol D. Jones, BA, Fernando Negro, MD, Katherine Darnell, BA, James L. Zehnder, MD

Blood (2004) 104 (11): 4033.

https://doi.org/10.1182/blood.V104.11.4033.4033

Published: 2004

Journal Articles

Homozygous factor V splice site mutation associated with severe factor V deficiency

Iris Schrijver, Marion A. Koerper, Carol D. Jones, James L. Zehnder

Blood (2002) 99 (8): 3063–3065.

https://doi.org/10.1182/blood.V99.8.3063

Published: 2002

Journal Articles

Expression of a single gene, BCL-6 , strongly predicts survival in patients with diffuse large B-cell lymphoma

Izidore S. Lossos, Carol D. Jones, Roger Warnke, Yasodha Natkunam, Herbert Kaizer, James L. Zehnder, Rob Tibshirani, Ronald Levy

Blood (2001) 98 (4): 945–951.

https://doi.org/10.1182/blood.V98.4.945

Published: 2001

Journal Articles

Involvement of Interleukin-10 (IL-10) and Viral IL-6 in the Spontaneous Growth of Kaposi’s Sarcoma Herpesvirus-Associated Infected Primary Effusion Lymphoma Cells

Karen D. Jones, Yoshiyasu Aoki, Yuan Chang, Patrick S. Moore, Robert Yarchoan, Giovanna Tosato

Blood (1999) 94 (8): 2871–2879.

https://doi.org/10.1182/blood.V94.8.2871

Published: 1999

Journal Articles

Calreticulin and Calreticulin Fragments Are Endothelial Cell Inhibitors That Suppress Tumor Growth

Sandra E. Pike, Lei Yao, Joyce Setsuda, Karen D. Jones, Barry Cherney, Ettore Appella, Kazuyasu Sakaguchi, Hira Nakhasi, Chintamani D. Atreya, Julie Teruya-Feldstein, Peter Wirth, Ghanshyam Gupta, Giovanna Tosato

Blood (1999) 94 (7): 2461–2468.

https://doi.org/10.1182/blood.V94.7.2461.419a26_2461_2468

Published: 1999

NARROW

Pediatric Preclinical Testing Consortium Evaluation of the Novel Anti-Microtubule Drug E7130 in Xenograft Models of Early T-Cell Precursor Acute Lymphoblastic Leukemia

An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD

Proliferating CLL Cells Express Abundant But Transcriptionally Compromised TP53 Protein

Whole Genome Sequence Analysis of Primary Myelofibrosis.

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

High-Throughput Immunoglobulin Gene Sequencing Quantifies Minimal Residual Disease in CLL with 10e-6 Sensitivity and Strongly Predicts Relapse After Allogeneic Hematopoietic Cell Transplantation

High-Throughput VDJ Sequencing Is Superior to Quantitative PCR and Flow Cytometry for the Quantification of Minimal Residual Disease In Chronic Lymphocytic Leukemia After Hematopoietic Cell Transplantation.

Identification of Novel LNK Mutations In Patients with Chronic Myeloproliferative Neoplasms and Related Disorders

Identification of a Novel Splice Donor Mutation In the Thrombopoietin Gene In a Philippine Family with Hereditary Thrombocythemia

Transforming Transfusion Practices: High Dose Aminocaproic Acid and Vitamin K for the Management of Thrombocytopenia

Mature Results of a Prospective Trial of Rituximab in Patients (Pt) with Post Transplant Lymphoproliferative Disorder (PTLD) Unresponsive or Ineligible for Reduced Immunosuppression (RIS).

Low Molecular Weight Heparin Modulates the Binding and Reactivity of Factor Xa towards Basic Pancreatic Trypsin Inhibitor: A Surface Plasmon Resonance and Kinetics Study.

Dasatinib (SPRYCEL®) in Patients (pts) with Previously Untreated Chronic Myelogenous Leukemia (CML) in Chronic Phase (CML-CP).

AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has Significant Activity in Imatinib-Resistant Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome Positive Acute Lymphoid Leukemia (Ph + ALL).

First Molecular Characterization of a Family with Combined FV and FVII Deficiency.

Identification of a Novel Factor V A2 Domain Tyrosine Deletion Mutation in a Patient with Factor V Deficiency and Bleeding.

Homozygous factor V splice site mutation associated with severe factor V deficiency

Expression of a single gene, BCL-6 , strongly predicts survival in patients with diffuse large B-cell lymphoma

Involvement of Interleukin-10 (IL-10) and Viral IL-6 in the Spontaneous Growth of Kaposi’s Sarcoma Herpesvirus-Associated Infected Primary Effusion Lymphoma Cells

Calreticulin and Calreticulin Fragments Are Endothelial Cell Inhibitors That Suppress Tumor Growth

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only